ACADIA Pharmaceuticals Inc. (ACAD) seems poised for a price surge based on its latest charts. The company focuses on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States.
Bullish Indications
#1 Symmetrical Triangle Pattern: The daily chart shows that the stock had recently formed a Symmetrical Triangle pattern. This is a continuation pattern and is characterized by two converging trend lines connecting a series of sequential peaks and troughs. This pattern is marked on the daily chart as purple color lines. The breakout from a symmetrical triangle pattern usually signifies a bullish move. Currently, the stock looks poised for a breakout from the symmetrical triangle pattern which is a possible bullish sign.
ACAD – Daily Chart
#2 Price above MAs: The price is currently above the short-term moving average of 50-day SMA as well as the longer-term moving average of 200-day SMA, indicating that the bulls are still in control. This is a positive indication.
#3 Bullish ADX: The ADX indicator shows that the +DI line is currently above the –DI line and the ADX line has started to move up from below the –DI and +DI lines. This indicates possible bullishness.
#4 Bullish Stoch: The %K line is above the %D line of the stochastic in the daily chart, and is also moving higher from oversold levels, indicating possible bullishness.
#5 Above Support Area: As you can see from the weekly chart, the stock has currently moved up from a resistance-turned-support level. This level is marked as a pink color dotted line. This looks like a good area for the stock to move higher. The stock is also trading above its 50-week SMA, indicating that the bulls are still in control.
ACAD – Weekly Chart
#6 Bullish MACD: The MACD line is above the MACD signal line in the weekly chart as well, indicating bullishness.
#7 Bullish RSI: In the weekly chart, the RSI is currently above 50 and moving higher. This is a possible bullish sign.
Recommended Trade (based on the charts)
Buy Levels: If you want to get in on this trade, you can purchase shares of ACAD above the price of around $18.80.
TP: Our target prices are $21.50 and $24.00 in the next 3-6 months.
SL: To limit risk, place stop-loss at $17.20. Note that the stop-loss is on a closing basis.
Our target potential upside is 14% to 28% in the next 3 to 6 months.
For a risk of $1.60, our target rewards are $2.70 and $5.20. This is a nearly 1:2 and 1:3 risk-reward trade.
In other words, this trade offers nearly 2x to 3x more potential upside than downside.
Risks to Consider
The stock may reverse its overall trend if it breaks down from the symmetrical triangle pattern with a high volume. The sell-off of the stock could also be triggered in case of any negative news, overall weakness in the market, or any regulatory changes in the sector.
Happy Trading!
Tara
'Invisible' AI Stock poised to be NVDA of 2025 [sponsor]It's clear there are powerful headwinds for NVDA in 2025. The world's biggest hedge fund is selling their shares and Amazon's Jeff Bezos is investing millions into a new Nvidia rival... Analysts on and off Wall Street say to load up on THIS ticker instead.